Orgad Laub
Amministratore Delegato presso Sealantium Medical Ltd.
Profilo
Orgad Laub is the founder and Chief Executive Officer of Sealantium Medical Ltd.
which is founded in 2011.
He is currently a Director at Rimonyx Pharmaceuticals Ltd.
Dr. Laub has also worked as a Director at Serono Corp.
and as a Professor at Weizmann Institute of Science.
Posizioni attive di Orgad Laub
| Società | Posizione | Inizio |
|---|---|---|
Rimonyx Pharmaceuticals Ltd.
 Rimonyx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rimonyx Pharmaceuticals Ltd. develops drugs targeted at glycosaminoglycan and protein interactions. It identified a series of novel anti-inflammatory compounds and has recently partnered its lead drug candidate, RX-111, for further preclinical and clinical development. It is focused on developing additional products for a variety of inflammatory and autoimmune indications. The company was founded in 2001 and is headquartered in Ness-Ziona, Israel | Direttore/Membro del Consiglio | - |
Sealantium Medical Ltd.
 Sealantium Medical Ltd. Medical SpecialtiesHealth Technology Sealantium Medical Ltd. develops a biodegradable bandage for the control of hemorrhage (bleeding), used in first aid, field trauma care, and surgery. The company was founded by Orgad Laub in 2011 and is headquartered in Netanya, Israel. | Amministratore Delegato | 01/01/2011 |
Precedenti posizioni note di Orgad Laub
| Società | Posizione | Fine |
|---|---|---|
| Serono Corp. | Direttore/Membro del Consiglio | - |
| Weizmann Institute of Science | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Rimonyx Pharmaceuticals Ltd.
Rimonyx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rimonyx Pharmaceuticals Ltd. develops drugs targeted at glycosaminoglycan and protein interactions. It identified a series of novel anti-inflammatory compounds and has recently partnered its lead drug candidate, RX-111, for further preclinical and clinical development. It is focused on developing additional products for a variety of inflammatory and autoimmune indications. The company was founded in 2001 and is headquartered in Ness-Ziona, Israel | Health Technology |
| Serono Corp. | |
Sealantium Medical Ltd.
Sealantium Medical Ltd. Medical SpecialtiesHealth Technology Sealantium Medical Ltd. develops a biodegradable bandage for the control of hemorrhage (bleeding), used in first aid, field trauma care, and surgery. The company was founded by Orgad Laub in 2011 and is headquartered in Netanya, Israel. | Health Technology |
- Borsa valori
- Insiders
- Orgad Laub
